Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC™) technology for clinical diagnostics and scientific discovery, today announced the appointment of Peter Heseltine, M.B., B.Ch., B.A.O., as Chief Medical Officer. At Singulex, Dr. Heseltine will have overall responsibility for clinical strategy, including scientific and medical affairs.
Help employers find you! Check out all the jobs and post your resume.